|
静脉吸毒人群流行病学比较新研究：肝炎比艾滋病易感染
中新云南新闻网 编辑：赵书勇 发布时间：2011-03-21 中新社昆明3月20日电 (记者 杨洋 张刚强)中科院昆明动物研究所20日传出消息，该所科研人员对中缅边境地区静脉吸毒人群艾滋病和肝炎流行病学比较研究取得进展，研究证实丙肝的感染率最高，而艾滋病的感染率最低。
据参与该项目科研人员周衍衡介绍，艾滋病、乙肝和丙肝是目前全球极为流行的3种传染病。由于都可通过血液传播，使得静脉吸毒人群比普通人群更容易传播这3种传染病。目前，国际和国内对云南省边境地区静脉吸毒人群艾滋病、乙肝和丙肝流行病学比较研究甚少。
为了解中缅边境地区上述三种传染病的流行情况，更科学地监测艾滋病跨境传播趋势，为中国和云南省制定艾滋病防治规划和进行干预活动提供科学依据。中科院昆明动物研究所动物模型与人类疾病机理重点实验室科研人员周衍衡和刘丰亮等人，对来自云南省德宏州的403名中国籍静脉吸毒者及与德宏州接壤的缅甸地区318名缅甸籍静脉吸毒者的艾滋病、乙肝和丙肝感染情况进行了比较研究。
结果发现，无论是在中国籍人群中，还是在缅甸籍人群中，丙肝的感染率都是最高的，而艾滋病的感染率最低。在进行中国和缅甸静脉吸毒人群的横向比较之后发现，中国籍静脉吸毒人群中感染艾滋病、乙肝和丙肝或同时感染其中2种或3种病毒的感染者比例都要高于缅甸籍静脉吸毒人群中的比例。分别对两国国籍静脉吸毒人群艾滋病感染率的跨年度纵向比较发现，中缅两国静脉吸毒人群的艾滋病感染率与往年相比均有一定程度的下降。
据悉，该研究已经得到了国家重大科技专项、国家自然科学基金、艾滋病亚洲区域项目等项目的资助及云南省疾病预防控制中心的协助。该研究成果近期已发表在美国公共科学图书馆期刊上。
艾滋病不治会早死，早治才康复 艾滋病不治会早死，早治才康复 艾滋病不治会早死，早治才康复 艾滋病不治会早死，早治才康复
 |
| 图示∶2010年12月即将出版的《中国特色医疗金鉴》登载的刘君主任及其机构 |
| |
|
|
Intravenous drug users relatively new epidemiological studies: hepatitis than AIDS vulnerability
New Yunnan News Editor: Zhao Shuyong Published :2011-03-21 China news agency, Kunming, March 20 (Reporters Yang Yang and Zhang Gangqiang) - CAS Kunming Institute of Zoology, 20, came news that the researchers of the China-Burma border areas of AIDS and hepatitis among injecting drug users progress in epidemiological comparative study, researchers confirmed that the highest prevalence of hepatitis C, while the lowest incidence of AIDS.
According to Zhou Yanheng researchers involved in the project description, AIDS, hepatitis B and hepatitis C is currently the world's most popular three kinds of infectious diseases. As can be spread through blood, intravenous drug users makes it easier than the general population spread of this infectious disease 3. At present, the international and domestic intravenous drug users in Yunnan border area of AIDS, hepatitis B and hepatitis C epidemiology little comparative study.
To understand the China-Burma border area of the three infectious diseases, and more scientific monitoring of trends in cross-border spread of AIDS, and the Yunnan province of China plans to develop AIDS prevention and intervention activities to provide scientific basis. CAS Kunming Institute of Zoology, Animal Models and Human Disease Mechanisms, Laboratory researchers Zhouyan Heng and Liu Fengliang and others, from 403 in Dehong in intravenous drug users and the Chinese state bordering Myanmar and Dehong region 318 Myanmar Membership intravenous drug users with AIDS, hepatitis B and hepatitis C infection were compared.
It was found, whether in the Chinese population, or in the Burmese population, hepatitis C infection rates are the highest, while the lowest incidence of AIDS. China and Myanmar during the horizontal comparison of intravenous drug users, found that Chinese intravenous drug users infected with HIV, hepatitis B and hepatitis C infection in one or both of 2 or 3 infection should be higher than the proportion of intravenous drug users in Myanmar nationals in proportion. The nationality of the two countries were HIV infection rates among injecting drug users found that multi-year longitudinal comparison, China and Burma have HIV infection rates among injecting drug users compared with previous years have decreased to some extent.
It is reported that the study has been a major national science and technology projects, the National Natural Science Foundation of China, AIDS projects such as the Asian regional project funded and Yunnan Center for Disease Control and Prevention for their assistance. The research results have been published recently in the United States Public Library of Science journal.
|
